Hep-Art Medical Devices develops bio-artificial liver system to support acute liver failure patients to liver recovery.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Amsterdam
State: Noord-Holland
Zip:
Country: The Netherlands
Hep-Art Medical Devices B.V. is a spin off company of the Academic Medical Center in Amsterdam. The company has developed a robust bio-artificial liver system, the AMC-BAL. The AMC-BAL has been developed to support acute liver failure (ALF) patients to liver recovery or to the moment of donor-liver availability. The AMC-BAL is an extracorporeal supportive device that treats the plasma of the patients and temporarily replaces liver functions. The core of the system is a bioreactor that is loaded with embedded liver cells (hepatocytes). When based on porcine liver cells, the system appeared safe during a first clinical phase 1 study with ALF patients.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2017 | Grant | 1 | $52.7k |
EASME - EU Executive Agency for SMEs EASME - EU Executive Agency for SMEs |
11/2015 | Pre Seed Round | 1 | - |
ACE Incubator ACE Incubator |
11/2015 | Pre Seed Round | 1 | - |
ACE Incubator ACE Incubator |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|